Works matching IS 2160763X AND DT 2022 AND VI 11
Results: 164
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1357, doi. 10.1002/cpdd.834
- Publication type:
- Article
Authorship.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1362, doi. 10.1002/cpdd.1190
- By:
- Publication type:
- Article
Challenges in the Development of Intravenous Neurokinin‐1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose‐Finding, Phase 1 Study of Intravenous Fosnetupitant.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1405, doi. 10.1002/cpdd.1183
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1394, doi. 10.1002/cpdd.1178
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1382, doi. 10.1002/cpdd.1174
- By:
- Publication type:
- Article
Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1440, doi. 10.1002/cpdd.1156
- By:
- Publication type:
- Article
Population Pharmacokinetics of Oral Brepocitinib in Healthy Volunteers and Patients.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1447, doi. 10.1002/cpdd.1163
- By:
- Publication type:
- Article
Population Pharmacokinetics of Oral Migalastat in Adolescents and Adults With and Without Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1367, doi. 10.1002/cpdd.1160
- By:
- Publication type:
- Article
Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsules in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1474, doi. 10.1002/cpdd.1159
- By:
- Publication type:
- Article
Bioequivalence of China‐ and Germany‐Manufactured Metformin Extended‐Release Tablets Under Fed and Fasted Conditions in Healthy Volunteers: A Randomized, Open‐Label, 2‐Way Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1430, doi. 10.1002/cpdd.1158
- By:
- Publication type:
- Article
Drug‐Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ‐56136379 (Bersacapavir).
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1419, doi. 10.1002/cpdd.1164
- By:
- Publication type:
- Article
Bioequivalence of Two Linezolid Tablets Under Fed and Fasting Conditions in Healthy Chinese Individuals.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1481, doi. 10.1002/cpdd.1155
- By:
- Publication type:
- Article
PKPD Modeling and Simulations to Support Biosimilar Development of Biphasic Insulin Aspart 30.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1457, doi. 10.1002/cpdd.1152
- By:
- Publication type:
- Article
Pharmacokinetics and Safety Study of HN0037, a Novel Anti‐Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1467, doi. 10.1002/cpdd.1138
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1241, doi. 10.1002/cpdd.833
- Publication type:
- Article
Bioequivalence of Pomalidomide Capsules in Fasting and Fed States in Healthy Male Volunteers: A Randomized, Open, Single‐Dose, Biperiodic, Double‐Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1246, doi. 10.1002/cpdd.1173
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1349, doi. 10.1002/cpdd.1169
- By:
- Publication type:
- Article
Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1284, doi. 10.1002/cpdd.1165
- By:
- Publication type:
- Article
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1294, doi. 10.1002/cpdd.1153
- By:
- Publication type:
- Article
An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1341, doi. 10.1002/cpdd.1150
- By:
- Publication type:
- Article
Population Pharmacokinetics of Heptanoate in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders Treated With Triheptanoin.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1264, doi. 10.1002/cpdd.1145
- By:
- Publication type:
- Article
An Open‐Label, Randomized Pharmacokinetic Study of 2 Formulations of Eldecalcitol Capsules Following Single Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1322, doi. 10.1002/cpdd.1144
- By:
- Publication type:
- Article
Pharmacokinetics of Amoxicillin and Clavulanate Potassium for Suspension (200 mg/28.5 mg) in Healthy Subjects: Sample Add Stabilizer Study and Food Effects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1314, doi. 10.1002/cpdd.1143
- By:
- Publication type:
- Article
Effect of Meal Timings and Meal Content on the AUC<sub>0‐12h</sub> of Mycophenolic Acid: A Simulation Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1331, doi. 10.1002/cpdd.1141
- By:
- Publication type:
- Article
Drug‐Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1253, doi. 10.1002/cpdd.1140
- By:
- Publication type:
- Article
Pharmacokinetics of Esomeprazole Magnesium After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1308, doi. 10.1002/cpdd.1139
- By:
- Publication type:
- Article
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1273, doi. 10.1002/cpdd.1136
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1125, doi. 10.1002/cpdd.832
- Publication type:
- Article
A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1130, doi. 10.1002/cpdd.1171
- By:
- Publication type:
- Article
Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1191, doi. 10.1002/cpdd.1154
- By:
- Publication type:
- Article
Pharmacokinetics, Bioequivalence, and Safety Studies of a Generic Selective Tyrosine Kinase Inhibitor Nilotinib Capsule Versus a Branded Product in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1233, doi. 10.1002/cpdd.1148
- By:
- Publication type:
- Article
Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI‐589 in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1136, doi. 10.1002/cpdd.1146
- By:
- Publication type:
- Article
A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1221, doi. 10.1002/cpdd.1142
- By:
- Publication type:
- Article
Pharmacokinetic and Safety Comparison of 2 Afatinib Dimaleate Tablets in Healthy Chinese Volunteers Under Fasted Conditions: A Randomized, Open‐Label, 2‐Period, Single‐Dose Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1177, doi. 10.1002/cpdd.1134
- By:
- Publication type:
- Article
A Reference‐Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open‐Label, Randomized, Single‐Dose, 3‐Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1147, doi. 10.1002/cpdd.1132
- By:
- Publication type:
- Article
Comparative Bioavailability of a Single Dose of Trametinib (TMT212) Containing 9% vs 11% Dimethyl Sulfoxide in Randomized Healthy Volunteers to Assess Long‐Term Storage at Room Temperature.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1203, doi. 10.1002/cpdd.1129
- By:
- Publication type:
- Article
The Safety, Toleration, and Pharmacokinetics of Two Intravenous Voriconazole Formulations in Healthy Chinese Volunteers After Increasing Dose Administrations.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1211, doi. 10.1002/cpdd.1126
- By:
- Publication type:
- Article
Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1165, doi. 10.1002/cpdd.1110
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1184, doi. 10.1002/cpdd.1108
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of Single‐Oral‐Dose Linagliptin: A Randomized, 2‐Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1157, doi. 10.1002/cpdd.1104
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, p. i, doi. 10.1002/cpdd.835
- Publication type:
- Article
ACCP Abstract Booklet.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, p. 1, doi. 10.1002/cpdd.1151
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1007, doi. 10.1002/cpdd.831
- Publication type:
- Article
A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1068, doi. 10.1002/cpdd.1147
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Parallel Controlled, Single‐Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1028, doi. 10.1002/cpdd.1135
- By:
- Publication type:
- Article
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1099, doi. 10.1002/cpdd.1133
- By:
- Publication type:
- Article
Population Pharmacokinetic/Pharmacodynamic Modeling of the Effect of Abrocitinib on QT Intervals in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1036, doi. 10.1002/cpdd.1111
- By:
- Publication type:
- Article
Clinical Formulation Bridging of Gefapixant, a P2X3‐Receptor Antagonist, for the Treatment of Chronic Cough.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1054, doi. 10.1002/cpdd.1105
- By:
- Publication type:
- Article
First‐in‐Human Single‐Ascending‐Dose, Multiple‐Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1012, doi. 10.1002/cpdd.1103
- By:
- Publication type:
- Article
A Pharmacokinetic Bioequivalence Study Comparing Different‐Strength and ‐Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1092, doi. 10.1002/cpdd.1101
- By:
- Publication type:
- Article